Validation of a tool to predict chemotherapy toxicity in older Indian patients with cancer
Not Applicable
- Conditions
- Health Condition 1: C768- Malignant neoplasm of other specified ill-defined sites
- Registration Number
- CTRI/2022/10/046865
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age >=60 years
2.Diagnosed with solid organ cancer
3.Planned for a new line of chemotherapy. The use of targeted agents and immunotherapy are permissible in combination with chemotherapy.
Exclusion Criteria
1.Patients receiving radical intent concurrent chemoradiotherapy
2.Patients who have received 2 or more prior lines of systemic therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method